Literature DB >> 6983911

Receptors for the complement C3d component and the Epstein-Barr virus are quantitatively coexpressed on a series of B-cell lines and their derived somatic cell hybrids.

V Jønsson, A Wells, G Klein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6983911     DOI: 10.1016/0008-8749(82)90474-9

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  6 in total

1.  Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).

Authors:  G R Nemerow; R Wolfert; M E McNaughton; N R Cooper
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

2.  Purification of the Epstein-Barr virus/C3d complement receptor of human B lymphocytes: antigenic and functional properties of the purified protein.

Authors:  G R Nemerow; M F Siaw; N R Cooper
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

3.  Antibody-independent activation of the classical pathway of complement by Epstein-Barr virus.

Authors:  H Martin; I McConnell; B Gorick; N C Hughes-Jones
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

4.  The role of receptors for complement in the induction of polyclonal B-cell proliferation and differentiation.

Authors:  T F Tedder; J J Weis; L T Clement; D T Fearon; M D Cooper
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

5.  Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.

Authors:  J D Fingeroth; J J Weis; T F Tedder; J L Strominger; P A Biro; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

6.  gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor.

Authors:  R Frade; M Barel; B Ehlin-Henriksson; G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.